Neurogene Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2017 | — | $136.9M | $20.9M |
| Jun 2017 | — | $124.6M | $27.1M |
| Sep 2017 | — | $114.1M | $47.1M |
| Dec 2017 | — | $98.9M | $52.0M |
| Mar 2018 | — | $85.8M | $66.6M |
| Jun 2018 | — | $90.7M | $99.1M |
| Sep 2018 | — | $76.7M | $86.7M |
| Dec 2018 | — | $72.7M | $76.9M |
| Mar 2019 | — | $71.5M | $74.2M |
| Jun 2019 | — | $72.3M | $72.7M |
| Sep 2019 | — | $66.9M | $66.3M |
| Dec 2019 | — | $141.7M | $143.1M |
| Mar 2020 | — | $137.1M | $139.4M |
| Jun 2020 | — | $128.7M | $129.6M |
| Sep 2020 | — | $200.3M | $201.2M |
| Dec 2020 | — | $191.2M | $192.6M |
| Mar 2021 | — | $179.0M | $178.4M |
| Jun 2021 | — | $167.1M | $164.2M |
| Sep 2021 | — | $154.9M | $154.9M |
| Dec 2021 | — | $-91.9M | $142.5M |
| Mar 2022 | — | $130.1M | $128.1M |
| Jun 2022 | — | $116.7M | $77.5M |
| Sep 2022 | — | $105.6M | $40.3M |
| Dec 2022 | — | $-145.7M | $82.0M |
| Mar 2023 | — | $-157.6M | $35.5M |
| Jun 2023 | — | $-169.1M | $31.1M |
| Sep 2023 | — | $-183.2M | $25.2M |
| Dec 2023 | — | $186.0M | $148.2M |
| Mar 2024 | — | $170.8M | $150.1M |
| Jun 2024 | — | $155.0M | $111.0M |
| Sep 2024 | — | $137.4M | $66.6M |
| Dec 2024 | — | $310.4M | $136.6M |
| Mar 2025 | — | $291.8M | $70.8M |
| Jun 2025 | — | $273.3M | $58.8M |
| Sep 2025 | — | $265.5M | $71.0M |
| Dec 2025 | — | $264.9M | $103.8M |
| Mar 2026 | — | $237.8M | $124.2M |
| Jun 2026 | — | $217.1M | $112.5M |